Belluscura PLC Result of General Meeting
08 Juillet 2024 - 1:45PM
RNS Regulatory News
RNS Number : 5382V
Belluscura PLC
08 July 2024
8 July 2024
Belluscura plc
("Belluscura", the
"Company"}
Result of General
Meeting
Belluscura plc (AIM: BELL), a
leading medical device developer focused on lightweight and
portable oxygen enrichment technology, announces that at the General Meeting held earlier today both
the resolutions put to the meeting were duly approved by
Shareholders:
|
Resolution
(*indicates special resolution)
|
Votes for
|
% of shares
voted
|
Votes
against
|
% of shares
voted
|
|
Resolution 1: To allot Shares
re. Loan Notes.
|
98,167,364
|
99.90%
|
101,411
|
0.10%
|
|
Resolution 2*: To disapply
Statutory
Pre-Emption Rights re. Loan Notes.
|
98,167,364
|
99.90%
|
101,411
|
0.10%
|
The Company is pleased to confirm
that, as announced on 2 July 2024, following Shareholder approval
for the Resolutions as they relate to the issue of the Loan Note
Placing, together with the recent Share Subscriptions for new
ordinary shares, the Company has raised total gross proceeds of
approximately £1.92 million.
In accordance with the terms of the
Loan Note Placing Agreement, following passing of the Resolutions,
the Placing Loan Notes will be issued on 9 July 2024.
The net proceeds of the Loan Note
Placing and Share Subscriptions will be used for working capital
purposes to support the growth in both the X-PLOR® and
DISCOV-RTM portable oxygen concentrator devices sales,
as set out in the Announcement and the Letter to Shareholders dated
2 July 2024.
Capitalised terms used in this announcement shall, unless
defined in this announcement or unless the context provides
otherwise, bear the same meaning ascribed to such terms in the
Announcement made by the Company at 14:30 on 2 July 2024 and the
letter to Shareholders dated 2 July 2024, which constituted a
supplement to the Circular dated 14 June 2024.
For
further information please contact:
|
Belluscura
plc
|
Tel: +44 (0)20 3128
8100
|
|
Adam Reynolds, Chairman
Robert Rauker, Chief Executive
Officer
Simon Neicheril, Chief Financial
Officer
|
|
|
|
|
|
SPARK Advisory
Partners Limited (Nomad)
|
Tel: +44 (0)20 3368
3550
|
|
Neil Baldwin / Jade Bayat
|
|
|
|
|
|
Dowgate
Capital Limited (Broker)
|
Tel: +44 (0)20 3903
7715
|
|
Russell Cook / Nicholas Chambers
|
|
|
|
|
|
MHP (Financial PR & Investor
Relations)
|
Tel: +44 (0)20 3128
8100
|
|
Katie Hunt / Matthew Taylor
|
belluscura@mhpgroup.com
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
ROMEAFXPELELEFA
Belluscura (LSE:BELL)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Belluscura (LSE:BELL)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
